Cognition Therapeutics, Inc.

Contributing Author

Recent Articles by Cognition Therapeutics, Inc.

10 hours	Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health CGTX -8.76% GlobeNewswire
May-08	Cognition Therapeutics Reports Topline Results Showing Oral Zervimesine (CT1812) Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy CGTX GlobeNewswire
May-07	Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update CGTX GlobeNewswire